Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease

Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients

(2012) Maria Teresa Pellecchia et al.   JOURNAL OF NEUROLOGY

Serum Insulinlike Growth Factor 1 as Possible Marker for Risk and Early Diagnosis of Parkinson Disease

(2011) Jana Godau   ARCHIVES OF NEUROLOGY

Mild Cognitive Impairment in Parkinson’s Disease

(2011) Dag Aarsland et al.   Current Neurology and Neuroscience Reports

Cognitive impairment in nondemented Parkinson's disease

(2011) Paolo Barone et al.   MOVEMENT DISORDERS

Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of healthy, fit older adults

(2011) D. Bellar et al.   NEUROSCIENCE

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

(2010) Alice S. Chen-Plotkin et al.   ANNALS OF NEUROLOGY

Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease

(2010) J. Godau et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis

(2010) D. Aarsland et al.   NEUROLOGY

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease

(2009) Joana B. Pereira et al.   MOVEMENT DISORDERS